Associated Papers
Genetics of brain arteriovenous malformations and cerebral cavernous malformations.
Hongo H et al.
Journal of Human Genetics, 2023
KRAS: From undruggable to a druggable Cancer Target.
Uprety D et al.
Cancer Treatment Reviews, 2020
Genomic heterogeneity of multiple synchronous lung cancer.
Liu Y et al.
Nature Communications, 2016
27767028 (PubMed )
Supplement: ncomms13200-s1.pdf
Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
Gremer L et al.
Human Mutation, 2011
PARG1, a protein-tyrosine phosphatase-associated RhoGAP, as a putative Rap2 effector.
Myagmar BE et al.
Biochemical and Biophysical Research Communications, 2005
Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling.
Klockow B et al.
Oncogene, 2000
Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.
Morcos P et al.
Molecular and Cellular Biology, 1996
Differing structural requirements for GTPase-activating protein responsiveness and NADPH oxidase activation by Rac.
Xu X et al.
The Journal of Biological Chemistry, 1994
Select a paper to view details